Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
US OPEN: US500 tests record highs as technology sector leads gains
DE40: Regulatory and diplomatic escalations amid holidays
Novo Nordisk - There Were Risks, Now It's Time for Opportunities.
US OPEN: Renewed optimism at the beginning of the week